Replies to post #98233 on Anavex Life Sciences Corp (AVXL)

[Biostockclub]

Stealthways,
I agree with your points. Nice thinking.

By any chance, have you had the opportunity to listen to the audio interview Kevindenver posted yesterday of the interview with Dr. M on a radio show?

Reason I'm asking: it's the first time I've heard him (M) state how well A2-73 performed preclinically for the MS indication. The overall interview was about Rett, but he touched upon AD, Parkinson's, and MS preclinical saying that the drug performed similarly in all these indications restoring cellular homeostasis. Note: he never mentioned the MTA or the other company's name, but he did tout A2-73 for MS.

If you haven't heard it (not too long), I encourage you to give a listen. It will bolster your confidence that he has known what we have(!) for a long time.

Incidentally, when he failed to mention MS at Oppenheimer presentation, or the MTA, or the BP collaboration, it gave me pause that something of a "hostile nature" could have been brewing. I think he has let his guard down a little (or it was an oversight or interest of time?)